DNA/RNA-based next-generation sequencing allows earlier diagnosis of neoplastic bile duct strictures, a prospective multicenter real-time study finds.

The metagenomics sequencing market is mainly fueled by the combined influence of several major factors. The growing prevalence of infectious diseases, including emerging and re-emerging pathogens, has ...

Nearly half of people diagnosed with advanced cancer over a recent 5-year period did not undergo next-generation sequencing, according to results of a retrospective cohort study.Rates improved over ...

Next-generation sequencing (NGS) is transforming research by delivering rapid, high-quality genetic data through streamlined workflows, automation, and advanced logistics. Eurofins Genomics combines ...

Criteria for NGS testing in MNs can reduce unnecessary tests, saving costs without affecting patient care quality. Six approval and six cancellation criteria guide appropriate NGS use, focusing on ...

Bulk harvest release testing for adventitious viruses is an integral part of biosafety for manufacturing biopharma products. Finding a testing strategy that works for diverse biologics modalities ...

The US Food and Drug Administration (FDA) on Thursday issued new draft guidance meant to establish the necessary performance characteristics for genetic sequencing tests used to diagnose infectious ...

The NGS kits market presents significant opportunities driven by advancements in genomic sequencing, especially in DNA and RNA preparation kits. Innovation is fueled by reduced sequencing costs and ...

Whole genome sequencing (WGS) delivers deep insights into genetics, but its reliability depends on aligning coverage depth and uniformity with the study’s goals. Current research and practical guides ...

NeoGenomics Inc. used its latest earnings call to underscore a solid growth story, with management striking a confident but measured tone. Double‑digit revenue gains, accelerating next‑generation ...